YOLFTbeta
Quantum Genomics SA

Quantum Genomics SA

ALQGC · PA · Healthcare / Biotechnology

0.072EUR+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.072
Open0.0734
Day Range0.072 – 0.0749
52-Week Range0.072 – 0.0749
Volume0
Market Cap5.03M
P/E (TTM)0.00
Forward P/E0.18
EPS-0.80
Dividend Yield0.00%
Beta-0.16
50-Day Avg0.0721
200-Day Avg0.0721

About

Quantum Genomics Société Anonyme is in the process of liquidation of its remaining assets. Previously, the company was engaged in the development of drugs to treat cardiovascular diseases. Quantum Genomics Société Anonyme was incorporated in 2005 and is headquartered in Paris, France.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Mathieu Bigois
  • Employees1
  • Headquarters6, rue Cambacérès, Paris, France, 75008, France
  • Websitehttps://quantum-genomics.com

Leadership

  • Mr. Mathieu BigoisCEO & Chairman of the Board

Financials

Income Statement

Currency: EUR2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Total Revenue19.20K19.20K19.20K19.20K17.40K324.30K144.14K003.69K1.55M1.83M3.14M2.52M19.80K10
Growth (%)-0.00%0.00%0.00%-9.38%+1763.82%-55.55%-100.00%--+41869.61%+18.23%+71.57%-19.85%-99.21%-99.95%
Cost of Revenue1.44M1.31M1.23M955.41K1.09M1.32M2.77M3.87M25.87K19.02K12.03K16.73M20.34M29.50M1.44M1.15M
Gross Profit-1.42M-1.29M-1.21M-936.21K-1.07M-999.64K-2.62M-3.87M-25.87K-15.33K1.53M-14.90M-17.21M-26.99M-1.42M-1.15M
Gross Margin-7382.12%-6738.17%-6310.55%-4876.10%-6150.93%-308.24%-1819.12%---415.95%99.22%-814.93%-548.31%-1073.02%-7169.57%-11453070.00%
Operating Expense18.32K91.13K28.97K124.73K832.28K1.42M1.69M2.34M10.27M13.58M12.29M1.93M2.91M3.10M1.72M327.53K
Operating Income-1.44M-1.38M-1.24M-1.06M-1.90M-2.42M-4.31M-6.22M-10.29M-13.60M-10.76M-16.83M-20.11M-30.08M-3.14M-1.47M
Operating Margin-7477.55%-7212.81%-6461.44%-5525.72%-10934.16%-745.46%-2990.22%---368912.10%-695.54%-920.28%-640.95%-1196.12%-15847.92%-14728350.00%
EBITDA-1.46M-1.36M-1.04M-1.05M-1.89M-2.45M-4.26M-6.19M-10.27M-13.55M-10.61M-14.67M-19.41M-30.20M-2.87M-1.47M
EBITDA Margin-7621.69%-7098.58%-5404.41%-5454.15%-10876.17%-755.48%-2953.07%---367593.57%-686.08%-802.24%-618.67%-1200.75%-14515.46%-14702370.00%
Net Income-1.38M-1.33M-857.88K-843.39K-1.54M-2.21M-3.76M-5.24M-9.38M-11.99M-9.08M-16.22M-17.36M-24.94M-3.17M-8.89M
Net Income Margin-7211.41%-6935.56%-4468.13%-4392.68%-8858.79%-680.49%-2611.57%---325286.35%-586.84%-887.04%-553.19%-991.45%-16018.12%-88926030.00%
R&D------1.56M2.28M4.55M8.00M4.87M-----
R&D as % of Total Revenue------1082.99%--217037.44%314.80%-----
Interest Expense102347218.61K11.99K19.80K222.21K0056.17K134.27K1.46M46.00K17.67K21.40K27.53K
Interest Expense % of Total Revenue0.53%0.18%0.38%96.92%68.91%6.11%154.16%--1523.96%8.68%79.61%1.47%0.70%108.11%275260.00%

Balance Sheet

Currency: EUR2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Total Assets845.90K845.89K850.38K1.06M1.69M4.75M10.54M14.51M13.92M18.48M14.78M32.80M21.24M23.66M3.75M354.65K
Total Liabilities534.82K804.81K521.06K1.97M3.32M4.88M2.52M2.72M5.05M6.61M5.37M8.15M11.57M20.05M3.31M2.81M
Total Equity11.08K-698.92K-410.68K-918.08K-1.63M-129.79K8.02M10.52M8.87M11.87M9.41M24.65M9.67M3.61M436.66K-2.46M
Cash68.56K139.27K79.79K51.98K334.13K3.32M4.55M2.20M6.09M14.79M11.16M27.15M13.55M10.40M3.55M301.02K
Total Debt-120.05K-418.64K1.05M3.31M6472.04K1.10K2.27K1.38K884.00K3.46M3.03M2.72M2.64M
Net Debt-68.56K-19.22K-79.79K366.66K718.74K-10.33K-4.55M-2.20M-6.09M-14.79M-11.16M-26.27M-10.09M-7.37M-830.55K2.34M

Cash Flow

Currency: EUR2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Operating Cash Flow--614.00K-987.00K-2.79M-3.14M-5.53M-7.98M-10.90M-10.43M-11.99M-17.02M-20.21M--
Investing Cash Flow--61.00K-112.00K-350.00K-368.00K-208.00K146.00K-231.00K-116.00K-411.00K-45.00K-152.54K--
Financing Cash Flow1.05M611.00K1.38M6.13M8.84M8.28M7.72M14.84M6.91M28.39M3.46M17.21M--
Capital Expenditure14.00K61.00K112.00K25.00K22.00K67.00K8.00K16.00K116.00K411.00K45.00K32.54K00
Free Cash Flow--675.00K-1.10M-2.82M-3.16M-5.60M-7.99M-10.92M-10.54M-12.40M-17.06M-20.21M--
FCF to OCF-109.93%111.35%100.90%100.70%101.21%100.10%100.15%101.11%103.43%100.26%100.00%--

Earnings

Report DateApr 14, 2016Oct 11, 2016Mar 30, 2017Oct 3, 2017Mar 29, 2018Oct 4, 2018Mar 28, 2019Oct 3, 2019Mar 26, 2020Oct 1, 2020Mar 25, 2021Jun 2, 2021Oct 6, 2021Jun 12, 2022Oct 12, 2022Mar 30, 2023May 26, 2023Oct 24, 2023Mar 13, 2024May 29, 2024Aug 28, 2024Nov 27, 2024Apr 30, 2025Sep 3, 2025Dec 3, 2025Feb 25, 2026
EPS Estimate0.000.000.000.000.000.000.000.000.00-0.310.080.00-0.19-0.260.000.000.000.000.000.000.000.000.000.000.000.00
EPS Actual-0.28-0.40-0.25-0.46-0.40-0.54-0.29-0.24-0.26-0.25-0.250.00-0.23-0.14-0.140.000.000.000.000.000.000.00-0.010.000.000.00
Surprise---------19.35%-412.50%--21.05%46.15%------------
TimingPre-marketPre-market-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-market-After-hoursAfter-hoursAfter-hours-Pre-marketAfter-hoursAfter-hours-------

Key Statistics & Ratios

Market Cap5.03M
Enterprise Value6.70M
Trailing P/E0.00
Forward P/E0.18
PEG Ratio0.00
Price / Sales502608.70
Price / Book0.21
EPS-0.80
Book Value-0.035
Revenue (TTM)10
Gross Profit (TTM)-1.15M
EBITDA-1.47M
Profit Margin0.00%
Operating Margin-17545000.00%
Return on Equity-156.81%
Return on Assets-44.89%
Shares Outstanding69.71M
Shares Float59.71M
Beta-0.16
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Mar 16, 2016217:216
  • Dec 13, 20131:18